Skeletal Muscle an Active Compartment in the Sequestering and Metabolism of Doxorubicin Chemotherapy.
Doxorubicin remains one of the most widely used chemotherapeutic agents however its effect on healthy tissue, such as skeletal muscle, remains poorly understood. The purpose of the current study was to examine the accumulation of doxorubicin (DOX) and its metabolite doxorubicinol (DOXol) in skeletal...
Main Authors: | Sergio Fabris, David A MacLean |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4581622?pdf=render |
Similar Items
-
Doxorubicin-dependent skeletal muscle atrophy: exercise and mitochondrial dysfunction
by: Gökhan Burçin Kubat, et al.
Published: (2024-02-01) -
Supplementation-induced change in muscle carnosine is paralleled by changes in muscle metabolism, protein glycation and reactive carbonyl species sequestering
by: Schön, M, et al.
Published: (2022) -
Formoterol reduces muscle wasting in mice undergoing doxorubicin chemotherapy
by: Edson Alves de Lima Junior, et al.
Published: (2024-01-01) -
Chemotherapy-Induced Molecular Changes in Skeletal Muscle
by: Mafalda Barbosa Pedrosa, et al.
Published: (2023-03-01) -
Prevention of Doxorubicin-Induced Autophagy Attenuates Oxidative Stress and Skeletal Muscle Dysfunction
by: Vivian Doerr, et al.
Published: (2020-03-01)